Delivery Order SPE2DB22D3102-SPE2DB25FL2DD
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.12 contract is for the delivery of 4,568,347,246 units of Naloxone HCl 4 mg Nasal Spray, a medication used to reverse opioid overdoses. The award is not set aside and was competitively bid. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,324,180 units of Naloxone HCL 4 mg Nasal Spray, an opioid overdose reversal medication. The contract has a ceiling value of $8,728.30 and a period of performance through January 16, 2024. The contract was awarded on a firm fixed-price basis and was not subject to any set-aside requirements. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,008,836 units of Naloxone HCl 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a ceiling value of $1,171.34 and a period of performance through April 24, 2025. This award is not set aside for any specific business category. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,976,359 units of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The firm-fixed-price contract has a ceiling value of $2,121.45 and a period of performance through January 21, 2025. The contract is not designated as a...
- This is a firm-fixed-price delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,118,096 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The total ceiling value of the contract is $1,372.92, with a period of performance running through February 3, 2025. This award is not designated as a set-aside contract....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,993.23 contract is for the delivery of 4 mg naloxone hydrochloride nasal spray, a medication used to reverse opioid overdose. The contract has a completion date of June 26, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,908,804 units of Naloxone HCL 4 mg Nasal Spray 2s, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,437.31 and a completion date of April 15, 2025. It is a firm fixed-price contract with no set-aside designation,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,120,273 units of Naloxone HCl 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a firm-fixed price of $1,799.28 and a completion date of May 5, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,061.84, is for the delivery of 4,567,475,840 units of Naloxone HCL 4 mg nasal spray, a critical medication used in the treatment of opioid overdoses. The contract is a firm-fixed-price delivery order with a period of performance through March 6, 2025. This award is part of a larger Indefinite...
- This is a $4,993.14 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,056,293 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of July 3, 2024 and was awarded on July 2, 2022. This delivery order is part of a larger Indefinite...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2DDDelivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,767,954 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used to reverse opioid overdoses. The contract has a ceiling value of $1,626.00 and a completion date of July 14, 2025. The contract is not set-aside and was awarded on July 11, 2025. AmerisourceBergen Drug Corp is a large, publicly-traded pharmaceutical company that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order represents a specific order under that broader IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/11/25 |